Jeremy Graff
Fortuna: 32 309 $ al 30/06/2026
Fortuna: 32 309 $ al 30/06/2026
Jeremy R.
Graff is currently Chairman at IN8bio, Inc. starting in 2026, Trustee at Wood Hudson Cancer Research Laboratory, Inc., and President & Chief Development Officer at Allarity Therapeutics, Inc. beginning in 2024.
Former roles include Chief Scientific Officer at IMV, Inc. from 2021 to 2024, Chief Development Officer & Senior VP-Research at HiberCell, Inc. from 2020 to 2021, and President & Chief Scientific Officer at Biothera Pharmaceuticals, Inc. (Delaware) from 2018 to 2020 as well as at Biothera, Inc. Education includes undergraduate studies at Thomas More University and a doctorate from the University of Kentucky.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/04/2026 | 24.881 ( 0,16 % ) | 32 096 $ | 30/06/2026 | |
IN8BIO, INC. 0 % | 09/05/2026 | 151 ( 0 % ) | 213 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| IN8BIO, INC. | Presidente | 28/02/2026 |
| ALLARITY THERAPEUTICS, INC. | Presidente | 03/10/2024 |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| IMV INC. | Director Técnico/Científico/I+D | 01/01/2024 |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Director Técnico/Científico/I+D | 01/03/2021 |
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Presidente | 01/06/2020 |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Presidente | 01/06/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 9 |
|---|---|
Biothera, Inc.
Biothera, Inc. Miscellaneous Commercial ServicesCommercial Services Develops natural gluco polysaccharide that engages and directs natural innate immune systems | Commercial Services |
Thomas More University
Thomas More University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kentucky
University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IMV, Inc.
IMV, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company | Health Technology |
Biothera Pharmaceuticals, Inc. (Delaware)
Biothera Pharmaceuticals, Inc. (Delaware) Medical/Nursing ServicesHealth Services Develops cancer immunotherapy | Health Services |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Hibercell, Inc.
Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which develops treatments to prevent cancer relapse and metastasis | Commercial Services |
Allarity Therapeutics, Inc.
Allarity Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics | Health Technology |
Wood Hudson Cancer Research Laboratory, Inc.
Wood Hudson Cancer Research Laboratory, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization that provides scientific research services for cancer causes, diagnosis, treatment and prevention | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.